Mandate

Vinge advises Capio in connection with acquisition of Scanloc

September 01, 2016

Capio Specialistkliniker AB has entered into an agreement to acquire all shares in Scanloc Healthcare AB.

Scanloc conducts operations relating to specialist care within eye disorders at clinics situated in Gothenburg and Kungsbacka. The company’s customers primarily consist of the Västra Götaland and Halland County Councils. Scanloc has 35 employees and will be part of Capio Medocular. Closing is scheduled for 30 September and is conditional upon the customary closing conditions from the salient public authorities.

Vinge’s team consisted of responsible partner Anders Strid together with, among others, Frida Bäckergren (project manager), Frida Mattsson (employment), Victor Ericsson (tax) and Gabriella Fossum (public procurement).

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024